[Effect of plasmapheresis and immunocorrective therapy on the status of the T-cell component of immunity in patients with autoimmune thyroiditis]
Kalinin AP, Rafibekov DS, Potemkina EE, Shabadin VN · 1994 · Problemy endokrinologii
Study data at a glance
- Participants or experimental model
- 104 patients studied: 22 plasmapheresis alone; 82 with added Thymalin; 49 hypothyroid patients also received hormone replacement
- Reported results
- The authors describe sustained clinical and T-cell changes after combined treatment, with follow-up over one year.
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- The 49 hormone-replacement patients are an overlapping subset, not a third independent group.
- Plasmapheresis and hormone replacement confound attribution to Thymalin.
- The abstract does not establish randomized allocation or a modern disease-modifying effect.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Original publication abstract checked; full methodological appraisal pending.
Recorded source-check date: 2026-11-05. This date does not imply a completed systematic review.
Citation and original source
Original source: Kalinin AP, Rafibekov DS, Potemkina EE, Shabadin VN. [Effect of plasmapheresis and immunocorrective therapy on the status of the T-cell component of immunity in patients with autoimmune thyroiditis] Problemy endokrinologii 1994.
Molekul research summary: https://molekul.io/research/auto-7971902. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry